WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

WuXi AppTec, a prominent Chinese company listed on the Shanghai Stock Exchange, has announced the sale of its cell and gene ...

(Bloomberg) -- WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to ...

China's WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum. The contract development and ...

WuXi AppTec said Tuesday it has entered into a definitive agreement to sell its WuXi Advanced Therapies operations at the Philadelphia Navy Yard to New York health care investment firm Altaris.

Dec 24 (Reuters) - China's WuXi AppTec (603259.SS), opens new tab said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and ...

The Biotechnology Innovation Organization (BIO) has said it is parting company with Wuxi AppTec, while voicing support for US legislation that would block Chinese biotechs from federal funding and ...

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the ...